Skip to main content
HomeNational Conference



May 26 - 29, 2026

The Logan Hotel
Philadelphia, PA



"One More Round"


philadelphia_landmarks_no_love.png

The ABFO National Conference is the leading event for Bioscience CFOs and senior finance professionals aspiring to be CFOs.

Join us to gain insights from industry thought leaders and discover why attendees return year after year.

 

 

Who should attend?


CFOs: As the biotech landscape evolves at unprecedented speed, CFOs find themselves at the center of transformation—not only managing capital, but shaping strategic direction. At ABFO, financial leaders will gain critical insights into emerging funding dynamics, M&A priorities and regulatory shifts that directly influence long term financial planning. You will walk away with a clearer understanding of how to balance innovation investment with disciplined fiscal governance, how to position your organization in a competitive capital market, and how to leverage partnerships, data, and operational models that accelerate growth. Ultimately, ABFO equips CFOs with the strategic foresight and practical tools needed to guide their companies through the next wave of scientific and market opportunity.

Aspiring CFOs: For future CFOs, ABFO offers a front row seat to the forces shaping the industry—and a clear view of the skills and strategic mindset required to lead in it. Attendees will gain exposure to evolving capital raising models and the financial frameworks that drive biotech from early discovery through commercialization. They’ll see firsthand how seasoned CFOs navigate uncertainty, build investor confidence, and translate complex science into clear value narratives.
More importantly, aspiring CFOs will leave with a deeper understanding of the competencies they must hone: strategic financial planning in a high risk, high reward environment; cross functional collaboration with R&D and clinical teams; and the ability to anticipate regulatory, market, and operational pressures before they materialize. The conference serves not just as an educational experience, but as a roadmap—illuminating the path toward becoming a financial leader who can guide a biotech organization through growth, challenges, and breakthrough moments.



Agenda

 

Tuesday, May 26

5 – 10pm

Opening Reception and Networking

The Logan Hotel

 

Wednesday, May 27

7:30 am

Breakfast

9:00 am

Welcome Remarks

Opening Keynote Address
“The cure wasn’t the end, it was the beginning” 

Tom Whitehead, Co-Founder Emily Whitehead Foundation


10:00 am

The CFO Market Outlook: Capital Costs, Liquidity, and Timing Decisions

Aamir Mekila of Bank of America Merrill Lynch will discuss how CFOs are adjusting financing strategy, balance sheet posture, and risk tolerance over the next 12–24 months. Aspiring CFOs gain insight into how market data translates into real decisions.

11:15 am

What Investors Want: A Candid Conversation with Investors and Biotech CFOs

Ray Camahort of Novo Holdings and other investors will share what they look for in potential investments, how companies can best articulate their story, and what drives investor confidence post-investment. This interactive session will help attendees understand how to position their company for success in private and public fundraisings.

12:15 pm

Lunch and Networking

1:15 pm

Afternoon Keynote Address:

Donovan McNabb, former Quarterback of the NFL Philadelphia Eagles

2:15 pm

Afternoon Breakout Sessions:

 

1.     Regulatory Update for CFOs: What’s Going on in Washington

Experts from Goodwin and others will provide the latest updates on legislation and regulatory priorities, including FDA developments.  Learn how these shifts may impact your development programs and company strategy.

 

2.   Liquidity and Treasury Strategies for Today’s Uncertain Environment

Capital Advisors Group and CFO’s will discuss strategies for managing cash effectively in a declining interest rate environment.  Understand the risk-return landscape and how to keep your most valuable asset—cash—safe and productive.
 

3:30 pm

Afternoon breakout sessions:

 

1.     AI for Finance Leaders: Best Practices to Implement and Utilize AI

CFOs and operational leaders will share real-world examples of implementing AI across corporate, clinical and operational processes.  Learn how to evaluate AI investments, ask the right diligence questions, and understand how AI can create efficiency and cost savings.

 

2.   How to Build an OUTSTANDING Company Culture

Vin Milano and other leaders will share lessons on building resilient, mission-driven cultures in both challenging and high-growth environments.  Learn how leadership, hiring and values shape organizations for long-term success.

4:30 pm

End of Day Closing Remarks

6 pm

Evening Social Event

F1 Cafe

 

Thursday, May 28

7:30 am

Breakfast

9 am

Welcome back remarks


Signature Keynote Address:
Macro Risk and the CFO: Navigating Volatility, Cycles, and Building Long‑Term Value

Joe Quinlan, Chief Market Strategies, Bank of America Merrill Lynch

10:00 am

Morning Breakout Sessions

 

1.     Working with Analysts: How CFOs Shape the Narrative Without Over‑Promising

Leading analysts and CFO’s will discuss how to ensure they fully understand and amplify your company’s narrative.  Learn when to engage analysts, how to communicate your science and strategy effectively, and how to build a feedback loop around investor questions. 

 

2.   Scaling the Finance Tech Stack: When Finance Teams Get the Timing Wrong

A discussion on selecting and scaling the right technology stack, including timing for ERP implementation.  Hear how finance teams can leverage systems to improve efficiency and support company growth.

11:15 am

Late Morning Breakout Sessions

 

1.     Compensation Trends, Equity, and Governance:  What CFO’s need to know

Review current macroeconomic and industry dynamics affecting life sciences—covering inflation, market performance, headcount actions, and compensation trends—and how they are reshaping rewards and equity program structure strategy. We will also highlight key 2026 proxy season and SEC regulatory developments and discuss approaches to optimizing equity programs and balancing cost, dilution, and talent retention (the war for talent is alive and well) for biotech companies.

 

2.   From VP Finance or Controller to CFO: Taking the Next Step

CFOs and executive recruiters will discuss career paths, critical experiences for advancement, and how candidates can position themselves for a first-time CFO or senior leadership role –especially when they haven’t “done it before."

12:15 pm

Lunch and Networking

1:15 pm

Featured Keynote Address:

Dr. Taryn Marie Stejskal, CEO & Founder of the Resilience Leadership Institute

2:15 pm

Afternoon Breakout Sessions

 

1.     M&A Through the CFO Lens: Engagement, Positioning and Valuation

Hear from business development and search-and-evaluation leaders at large companies.  Learn how to approach strategic partners, position your asset within their priorities, and understand how they assess alignment with existing or emerging strategic pillars.

 

2.   IPO Readiness: Preparing the Organization for an IPO

Hear from experienced CFOs and advisors on the critical decisions, timing, and investments required on the path to an IPO. Learn best practices, pitfalls to avoid, and how to influence and manage the transition from private to public.

3:15 pm

Late Afternoon Breakout Sessions

 

1.     Strategic Financial Planning for CFOs

This session contrasts strategic planning with traditional budgeting, highlighting practical tools for operating effectively amid uncertainty.  Learn to use disciplined scenario planning, define decision split points, set defensible base cases, and manage key constraints such as capital, headcount, and timelines. 

 

2.   Enterprise Risk and How to Mitigate It

Learn about emerging areas of risk, how to build a stage-appropriate insurance program, and the role insurance plays in IPO readiness.  Gain practical insights on securing strong coverage and competitive rates as your company evolves.

4:30 pm

End of Day Closing Remarks

6 pm

Evening Social Event at the Franklin Institute

(Attendees may visit the Universal Theme Parks: The Exhibition beginning at 5:30 pm.)

A group photo will be taken on the Franklin Institute stairs at 6:15 pm, followed by an evening of science, entertainment, food, drinks, and exploration.

 

Friday, May 29

7:30 am

Breakfast

9 am

The Road to Commercialization

This panel will explore the critical steps companies must take to prepare for successful commercialization, from early planning through post‑approval execution. Panelists will discuss how to build credibility into your pitch deck through strategic alignment, market research, pricing strategy, and robust financial modeling. The session will also address coordination across Sales and Market Access, including gross‑to‑net considerations such as accrual methodologies, prompt pay, chargebacks, DSA fees, and rebates.

Attendees will gain practical insights into commercialization infrastructure decisions, including 3PL and contracting models, 340B strategy, and the timing of systems and process implementation—leveraging AI where appropriate. The discussion will further examine how far in advance of FDA approval companies should prepare, when to build out a sales force, and how evolving healthcare policy changes can impact launch readiness and long‑term commercial success.

10:10 am

Group Discussions: Off‑the‑Record Peer Conversations

Join peers from companies of similar size, stage, or region for small group roundtables.  Discuss shared challenges, trade solutions, and build ongoing connections for support and collaboration.

11 am

Conference Closing Remarks

 

 


AdobeStock_165579884-35pct.png

Thank you to our ABFO Conference Sponsors!


Past Conferences

2025 ABFO National Conference
San Diego, CA

Insert a link here

Insert a link here

Insert a link here

Insert a link here

Insert a link here

Insert a link here

Insert a link here

Insert a link here